Please ensure Javascript is enabled for purposes of website accessibility

Federal Circuit reverses claim construction but affirms infringementNovember 17, 2006

Abraxis Bioscience (formerly AstraZeneca) is the holder of three patents on an improved formulation of an anesthetic, DIPRIVAN

← Return to News & Events

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up